Purine analogs in the treatment of chronic lymphocytic leukemia
Prophylactic strategies to meet infectious complications in fludarabine-treated CLL
Is there a place for 2-CDA in the treatment of B-CLL?
Prognostic factors in chronic lymphocytic leukemia